Mogamulizumab‐induced granulomatous dermatitis of the scalp: a distinct entity associated with clinical response. (11th June 2022) - Pacaud, A.; Criquet, E.; Durlach, A.; Menguy, S.; Bagot, M.; Ehret, M.; Visseaux, L.; Beylot‐Barry, M.; Pham‐Ledard, A.; Grange, F.